Peptide OEM and CDMO Compared
Choose a model based on development ownership, technical complexity and documentation needs.
Choose a model based on development ownership, technical complexity and documentation needs.
Align formulation, cycle, container, presentation, testing and packaging requirements.
Verify legal entity, facility role, certificates, communication, export support and batch evidence.
Sequence behavior, equipment fit, purification burden and raw-material controls can change with scale.
Plan route, purification, impurity understanding and analytical controls before scale-up.
Define sequence, modifications, counter-ion, purity target, scale and intended application.
A strong brief reduces clarification cycles and makes commercial assumptions visible.
Compare technical fit, development ownership, analytical depth, scale-up evidence, documentation and communication.